Islay Capital Management, LLC Biogen Inc. Transaction History

Islay Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$259.0 - $414.71 $120,694 - $193,254	-466 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $32,069 - $37,571	132 Added 39.52%	466 $130,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $22,770 - $26,291	86 Added 34.68%	334 $95,000
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $34,919 - $46,244	-135 Reduced 35.25%	248 $66,000
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $16,668 - $21,144	62 Added 19.31%	383 $121,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $70,639 - $97,606	321 New	321 $95,000

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Islay Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Islay Capital Management, LLC with notifications on news.